Legal Disclaimer

This page provides general legal orientation for Australia, not legal advice. Regulations change frequently. Always verify current rules with TGA and consult a qualified professional.

Peptide Legal Status in Australia

Restrictive

Australia regulates peptides through the TGA under the Therapeutic Goods Act 1989. GLP-1 agonists are Schedule 4 (Prescription Only Medicine). The TGA actively enforces against illegal advertising and unauthorized imports. Research peptides without TGA approval are generally prohibited from sale and importation. Australia's regulatory framework is among the strictest for peptides.

Regulator

TGA (Therapeutic Goods Administration) — Official website

Key Facts

Regulatory Stance
restrictive
Compounding Allowed
Yes
Telehealth Prescribing
Yes

Compounding Pharmacy Rules

Compounding pharmacies operate under TGA oversight and Pharmacy Board of Australia guidelines. Section 10 allows pharmacists to compound for individual patients. The TGA has specific compounding standards (PIC/S Guide to GMP). The 2024 FDA Category 2 listings do not directly apply, but the TGA monitors international regulatory actions.

Telehealth Prescribing

Telehealth prescribing is legal in Australia. AHPRA-registered medical practitioners may prescribe via telehealth with appropriate clinical assessment. Online pharmacies must be registered with the Pharmacy Board of Australia. The TGA prohibits advertising of prescription-only medicines, including GLP-1 agonists, to the public.

Peptide Categories in Australia

Approved

Semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro), liraglutide (Saxenda) — all TGA-registered as Schedule 4 prescription medicines. Ozempic supply has been subject to PBS restrictions and shortages.

Research / Unapproved

BPC-157, TB-500, GHRP-2, GHRP-6 — not TGA-registered. Importation without TGA approval is prohibited. The TGA and Australian Border Force may seize unauthorized peptide imports. Personal importation scheme has strict limits.

Banned / Restricted

Peptides not registered on the ARTG (Australian Register of Therapeutic Goods) cannot be legally supplied. The TGA has issued infringement notices for illegal advertising of prescription peptides. WADA-prohibited peptides face additional import controls.

Key Legislation

  • Therapeutic Goods Act 1989
  • Poisons Standard (SUSMP)
  • Customs (Prohibited Imports) Regulations 1956

Peptides in Australia: FAQ

Sources

Peptide Laws in Other Countries

United KingdomCanadaEuropean UnionSingaporeUnited Arab EmiratesNew ZealandGermanyNetherlandsFranceSpainHong KongJapanSouth Korea